New Classifications of Five Distinct “Sleep” Profi... ...
Science in the Age of AI | AI for Science Forum...
Ask the Heart Doctor | Heart Valve Disease and Sur...
High-speed imaging tracks live brain cell activity...
NAD⁺ restores memory in Alzheimer's disease models...
Mark Cuban: A Master Disrupter for American Health...
Teen girls facing the most adversity showed the biggest gain...
September 15,2026
Specialized imaging reveals hormone-driven brain changes...
September 14,2026
Submillimeter MRI reveals brain hubs that guide risky decisi...
September 12,2026
Risk of herpes zoster among breast cancer survivors in Japan...
September 11,2026
Three proteins help organs tailor shared circadian clock to ...
September 10,2026
Should you worry about melatonin and heart failure? The evid...
December 02,2025
Category
Traditional Medicine
Q & A
Wellness
Drug Discovery
Technology & AI
Clinical Pearl Series
Breakthroughs
Immunology & Rheumatology
Reproduction
Hepatobiliary&Pancreas Surgery
Most Read
Blood Pressure Chart With Readings By Age and Sex

Blood Pressure Chart With Readings By Age and Sex

Blood Pressure Chart With Readings By Age and SexAverage Ranges Show Normal Pressure On the ArteriesBySheryl Huggins SalomonUpdated on April 21, 2023Medically reviewed byJeffre
Cardiovascular Diseases April 07,2024
Blood Pressure Chart With Readings By Age and Sex

Blood Pressure Chart With Readings By Age and Sex

Blood Pressure Chart With Readings By Age and SexAverage Ranges Show Normal Pressure On the ArteriesBySheryl Huggins SalomonUpdated on April 21, 2023Medically reviewed byJeffre
Cardiovascular Diseases April 07,2024
Pelage Pharmaceuticals Advances Hair Loss Treatment with Phase 2 Study and $14M Funding

Pelage Pharmaceuticals Advances Hair Loss Treatment with Phase 2 Study and $14M Funding

Pelage Pharmaceuticals has commenced dosing the first patients in its Phase 2a clinical trial for PP405, a novel topical treatment designed to reactivate dormant hair follicle stem cells.
Dermatology August 14,2024
Pelage Pharmaceuticals Advances Hair Loss Treatment with Phase 2 Study and $14M Funding

Pelage Pharmaceuticals Advances Hair Loss Treatment with Phase 2 Study and $14M Funding

Pelage Pharmaceuticals has commenced dosing the first patients in its Phase 2a clinical trial for PP405, a novel topical treatment designed to reactivate dormant hair follicle stem cells.
Dermatology August 14,2024
Blood Types: What Letters, Positive, and Negative Signs Mean

Blood Types: What Letters, Positive, and Negative Signs Mean

Blood Types: What Letters, Positive, and Negative Signs MeanWhat to Know About Your Blood TypeByNancy LeBrunPublished on September 15, 2023Medically reviewed byAnju Goel, MDYou
Oncology March 17,2024
Blood Types: What Letters, Positive, and Negative Signs Mean

Blood Types: What Letters, Positive, and Negative Signs Mean

Blood Types: What Letters, Positive, and Negative Signs MeanWhat to Know About Your Blood TypeByNancy LeBrunPublished on September 15, 2023Medically reviewed byAnju Goel, MDYou
Oncology March 17,2024
Today's News
GOSH BRC Showcase 2025 - Genomic medicine...
Can a twice-a-year shot help end the HIV...
Announcement of the 2025 Nobel Prize in ...
Reprogramming Stem Cells Could Cure Type...
Why MDMA did NOT get FDA approval...
More News
A brief history of drug-fueled combatants

A brief history of drug-fueled combatants

by Colin Davidson,The ConversationA chess piece depicting a berserker biting his shield. Credit:National Museums Scotland/Wikimedia Commons,CC BY-SAMy friend Luke used to drink a pin
Breakthroughs January 26,2024
A brief history of drug-fueled combatants

A brief history of drug-fueled combatants

by Colin Davidson,The ConversationA chess piece depicting a berserker biting his shield. Credit:National Museums Scotland/Wikimedia Commons,CC BY-SAMy friend Luke used to drink a pin
Breakthroughs January 26,2024
Researchers reveal molecular mechanism of cytokine storm induced by coronavirus

Researchers reveal molecular mechanism of cytokine storm induced by coronavirus

by Zhang Nannan,Chinese Academy of SciencesSARS-CoV-2 stabilizes host mRNAs to induce cytokine storm. Credit: Xue Yuanchao's groupIn the past four years, the pathogen responsible for Coronav
Immunology & Rheumatology January 26,2024
Researchers reveal molecular mechanism of cytokine storm induced by coronavirus

Researchers reveal molecular mechanism of cytokine storm induced by coronavirus

by Zhang Nannan,Chinese Academy of SciencesSARS-CoV-2 stabilizes host mRNAs to induce cytokine storm. Credit: Xue Yuanchao's groupIn the past four years, the pathogen responsible for Coronav
Immunology & Rheumatology January 26,2024
Study identifies factors associated with long-term use of FDA-approved anti-obesity medications

Study identifies factors associated with long-term use of FDA-approved anti-obesity medications

byCleveland ClinicPercentage of patients who were persistent with antiobesity medication (AOM) at early stage, medium term, and long term, by AOM agent. [Color figure can be viewed atwiley
Breakthroughs January 26,2024
Study identifies factors associated with long-term use of FDA-approved anti-obesity medications

Study identifies factors associated with long-term use of FDA-approved anti-obesity medications

byCleveland ClinicPercentage of patients who were persistent with antiobesity medication (AOM) at early stage, medium term, and long term, by AOM agent. [Color figure can be viewed atwiley
Breakthroughs January 26,2024
Vosoritide beneficial for children younger than 5 years with achondroplasia

Vosoritide beneficial for children younger than 5 years with achondroplasia

by Elana GotkineFor children with achondroplasia, vosoritide is associated with a gain in the change in height Z score from baseline and a mild adverse event profile, according to a study published in
Breakthroughs January 26,2024
Vosoritide beneficial for children younger than 5 years with achondroplasia

Vosoritide beneficial for children younger than 5 years with achondroplasia

by Elana GotkineFor children with achondroplasia, vosoritide is associated with a gain in the change in height Z score from baseline and a mild adverse event profile, according to a study published in
Breakthroughs January 26,2024
Study finds Paxlovid treatment does not reduce risk of long COVID

Study finds Paxlovid treatment does not reduce risk of long COVID

byUniversity of California, San FranciscoIn all models, treatment with oral nirmatrelvir was not associated with lower odds of patient reported Long COVID symptoms with confidence intervals that
Breakthroughs January 26,2024
Study finds Paxlovid treatment does not reduce risk of long COVID

Study finds Paxlovid treatment does not reduce risk of long COVID

byUniversity of California, San FranciscoIn all models, treatment with oral nirmatrelvir was not associated with lower odds of patient reported Long COVID symptoms with confidence intervals that
Breakthroughs January 26,2024
FDA looking into new risks with popular weight-loss drugs

FDA looking into new risks with popular weight-loss drugs

by Robin FosterThe U.S. Food and Drug Administration is investigating reports of additional dangers linked to several wildly popular weight-loss drugs.In aquarterly reportissued this week,
Breakthroughs January 26,2024
FDA looking into new risks with popular weight-loss drugs

FDA looking into new risks with popular weight-loss drugs

by Robin FosterThe U.S. Food and Drug Administration is investigating reports of additional dangers linked to several wildly popular weight-loss drugs.In aquarterly reportissued this week,
Breakthroughs January 26,2024
White house could punish big pharma's high prices by removing patents

White house could punish big pharma's high prices by removing patents

by Dennis ThompsonThe Biden administration is flexing some federal muscle in its push for lower drug prices, warning pharmaceutical companies that it might use its authority to cancel patent protectio
Breakthroughs January 26,2024
White house could punish big pharma's high prices by removing patents

White house could punish big pharma's high prices by removing patents

by Dennis ThompsonThe Biden administration is flexing some federal muscle in its push for lower drug prices, warning pharmaceutical companies that it might use its authority to cancel patent protectio
Breakthroughs January 26,2024
Tobacco smoke exposure linked to increased risk of tuberculosis

Tobacco smoke exposure linked to increased risk of tuberculosis

by Brandon Chase,Massachusetts General HospitalAnalysis of BAL cells by flow cytometry. (A) The total number of viable BAL cells from non-smokers and smokers was assessed using a NucleoCounter (
Public Health & Prevention January 26,2024
Tobacco smoke exposure linked to increased risk of tuberculosis

Tobacco smoke exposure linked to increased risk of tuberculosis

by Brandon Chase,Massachusetts General HospitalAnalysis of BAL cells by flow cytometry. (A) The total number of viable BAL cells from non-smokers and smokers was assessed using a NucleoCounter (
Public Health & Prevention January 26,2024
Discovery unveils immune system's guardian: Ikaros

Discovery unveils immune system's guardian: Ikaros

byMonash UniversityCredit: Pixabay/CC0 Public DomainIn a scientific breakthrough that aids our understanding of the internal wiring of immune cells, researchers at Monash University in Australia
Immunology & Rheumatology January 26,2024
Discovery unveils immune system's guardian: Ikaros

Discovery unveils immune system's guardian: Ikaros

byMonash UniversityCredit: Pixabay/CC0 Public DomainIn a scientific breakthrough that aids our understanding of the internal wiring of immune cells, researchers at Monash University in Australia
Immunology & Rheumatology January 26,2024
New weight-loss drug Zepbound is now available, company says

New weight-loss drug Zepbound is now available, company says

by Robin FosterThe newly approved weight-loss medication known as Zepbound is now available for patients to take, drug maker Eli Lilly announced Tuesday."Today opens another chapter for adults li
Breakthroughs January 26,2024
New weight-loss drug Zepbound is now available, company says

New weight-loss drug Zepbound is now available, company says

by Robin FosterThe newly approved weight-loss medication known as Zepbound is now available for patients to take, drug maker Eli Lilly announced Tuesday."Today opens another chapter for adults li
Breakthroughs January 26,2024
More News
Week’s Top
Podcasts
... Health spending has been rising across rich countries with different systems ... ... GOSH BRC Showcase 2025 - Genomic medicine ... ... At what age do people experience depression for the first time? Depression can affect people over long periods of their lives. Some people experience this condition continuously, while for others, it occu...
FIND US ON
ABOUT
Who We Are
Contact Us
Editorial Team
Sitemap
Policy
Privacy Policy
Advertising Policy
Editorial Policy
Corrections Policy
Medical Disclaimer
Alliance
wmo.com
sleep.net
pharm.net
doctors.net
worldsleep.com